madiha derouazi
Speransa Therapeutics GmbH
Frankfurt, Germany
Associate Editor
Cancer Immunity and Immunotherapy
Speransa Therapeutics GmbH
Frankfurt, Germany
Associate Editor
Cancer Immunity and Immunotherapy
Medical Research Council Centre for Drug Safety Science, Department of Molecular and Clinical Pharmacology, Institute of Translational Medicine, University of liverpool
Liverpool, United Kingdom
Associate Editor
Cancer Immunity and Immunotherapy
University of Texas MD Anderson Cancer Center
Houston, United States
Associate Editor
Cancer Immunity and Immunotherapy
Jilin University
Changchun, China
Associate Editor
Cancer Immunity and Immunotherapy
TCG Lifesciences (India)
Calcutta, India
Associate Editor
Cancer Immunity and Immunotherapy
University of Notre Dame
Notre Dame, United States
Associate Editor
Cancer Immunity and Immunotherapy
Moffitt Cancer Center
Tampa, United States
Associate Editor
Cancer Immunity and Immunotherapy
University of Navarra
Pamplona, Spain
Associate Editor
Cancer Immunity and Immunotherapy
University Medical Center Groningen
Groningen, Netherlands
Associate Editor
Cancer Immunity and Immunotherapy
Baylor College of Medicine
Houston, United States
Associate Editor
Cancer Immunity and Immunotherapy
Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences
Beijing, China
Associate Editor
Cancer Immunity and Immunotherapy
Second University of Naples
Naples, Italy
Associate Editor
Cancer Immunity and Immunotherapy
Center for Immuno-Oncology/Siena University Hospital
Siena, Italy
Associate Editor
Cancer Immunity and Immunotherapy
National Cancer Institute Foundation (IRCCS)
Milan, Italy
Associate Editor
Cancer Immunity and Immunotherapy
City of Hope National Medical Center
Duarte, United States
Associate Editor
Cancer Immunity and Immunotherapy
Universitatsklinikum Hamburg-Eppendorf, Zentrum für Operative Medizin, Klinik und Poliklinik für Gynäkologie
Hamburg, Germany
Associate Editor
Cancer Immunity and Immunotherapy